1. Home
  2. LOB vs STOK Comparison

LOB vs STOK Comparison

Compare LOB & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$39.08

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.20

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
STOK
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
LOB
STOK
Price
$39.08
$29.20
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$40.00
$34.50
AVG Volume (30 Days)
337.0K
712.6K
Earning Date
01-21-2026
03-17-2026
Dividend Yield
0.30%
N/A
EPS Growth
31.95
N/A
EPS
2.23
0.68
Revenue
$480,778,000.00
$205,632,000.00
Revenue This Year
$34.85
$430.24
Revenue Next Year
$14.31
N/A
P/E Ratio
$17.65
$43.03
Revenue Growth
19.32
1128.17
52 Week Low
$22.68
$5.35
52 Week High
$42.89
$38.69

Technical Indicators

Market Signals
Indicator
LOB
STOK
Relative Strength Index (RSI) 59.60 44.58
Support Level $38.52 $28.75
Resistance Level $42.89 $30.96
Average True Range (ATR) 1.49 2.05
MACD 0.22 -0.32
Stochastic Oscillator 45.73 35.86

Price Performance

Historical Comparison
LOB
STOK

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: